Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Non-Hodgkin's lymphomas, version 2.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.Academic Radiology|February 20, 2007
FDG-PET lymphoma demonstration project invitational workshopGary J Kelloff, Daniel M Sullivan, Wyndham Wilson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Non-Hodgkin's lymphomas, version 4.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin LymphomaAlison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016Steven M Horwitz, Andrew D Zelenetz, Leo I Gordon, et al.Pageof 21